Interim results of a first-in-human, dose escalation and expansion study of PLB-1004, an irreversible inhibitor of exon 20 insertion mutations in patients with non-small cell lung cancer

被引：3
|
作者：
Yang, Jinji
Wu, Yilong
Huang, Meijuan
Zhao, Yanqiu
Zhao, Jun
Zhou, Jianying
Mao, Ying
Wang, Huimin
Fan, Yun
Chung, David
Schaab, Kevin
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT102
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [2] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [3] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    Signal Transduction and Targeted Therapy, 4
  • [4] New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations
    David, Gil-Sierra Manuel
    del Pilar, Briceno-Casado Maria
    Cristina, Moreno-Ramos
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 934 - 943
  • [5] Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancer
    Huang, Wei-Sheng
    Li, Feng
    Gong, Yongjin
    Zhang, Yun
    Youngsaye, Willmen
    Xu, Yongjin
    Zhu, Xiaotian
    Greenfield, Matthew T.
    Kohlmann, Anna
    Taslimi, Paul M.
    Toms, Angela
    Zech, Stephan G.
    Zhou, Tianjun
    Das, Biplab
    Jang, Hyun G.
    Tugnait, Meera
    Ye, Yihua E.
    Gonzalvez, Francois
    Baker, Theresa E.
    Nadworny, Sara
    Ning, Yaoyu
    Wardwell, Scott D.
    Zhang, Sen
    Gould, Alexandra E.
    Hu, Yongbo
    Lane, Weston
    Skene, Robert J.
    Zou, Hua
    Clackson, Tim
    Narasimhan, Narayana I.
    Rivera, Victor M.
    Dalgarno, David C.
    Shakespeare, William C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
  • [6] The landscape of EGFR exon 20 insertion mutations in Chinese patients with non-small cell lung cancer.
    Xu, Shun
    Fu, Zhichao
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Mechanisms of resistance to BAY 2927088, the first reversible inhibitor targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Uzunbas, Gizem Karsli
    McVeigh, Quinn
    Gupta, Akansha
    Hoyt, Stephanie
    Doucette, Kristen
    Keshishian, Hasmik
    Carr, Steven
    Yang, Xiaoping
    Root, David
    Cherniack, Andrew D.
    Siegel, Franziska
    Siegel, Stephan
    Meyerson, Matthew
    Greulich, Heidi
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [8] Mechanisms of resistance to BAY 2927088, the first reversible inhibitor targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Uzunbas, Gizem Karsli
    McVeigh, Quinn
    Gupta, Akansha
    Hoyt, Stephanie
    Cherniack, Andrew
    Siegel, Franziska
    Siegel, Stephan
    Meyerson, Matthew
    Greulich, Heidi
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
    Wang, Mengzhao
    Yang, James Chih-Hsin
    Mitchell, Paul L.
    Fang, Jian
    Camidge, D. Ross
    Nian, Weiqi
    Chiu, Chao-Hua
    Zhou, Jianying
    Zhao, Yanqiu
    Su, Wu-Chou
    Yang, Tsung-Ying
    Zhu, Viola W.
    Millward, Michael
    Fan, Yun
    Huang, Wen-Tsung
    Cheng, Ying
    Jiang, Liyan
    Brungs, Daniel
    Bazhenova, Lyudmila
    Lee, Chee Khoon
    Gao, Bo
    Xu, Yan
    Hsu, Wei-Hsun
    Zheng, Li
    Janne, Pasi A.
    CANCER DISCOVERY, 2022, 12 (07) : 1676 - 1689
  • [10] Phase I/II study of osimertinib in EGFR exon 20 insertion mutations in non-small cell lung cancer patients: AEX20.
    Ichihara, Eiki
    Yasuda, Hiroyuki
    Takashima, Yuta
    Zenke, Yoshitaka
    Takeuchi, Shinji
    Morise, Masahiro
    Hotta, Katsuyuki
    Sato, Mineyoshi
    Matsumoto, Shingo
    Tanimoto, Azusa
    Matsuzawa, Reiko
    Kiura, Katsuyuki
    Terai, Hideki
    Ikemura, Shinnosuke
    Goto, Koichi
    Soejima, Kenzo
    CANCER RESEARCH, 2021, 81 (13)
12345